Prof. Dr. Evelyn Gaffal
Otto-von-Guericke-Universität Magdeburg
Leipziger Str. 44
39120
Magdeburg
Tel.:+49 391 6715249
Profil
Vita
2020 |
apl. Professor University of Magdeburg, Dept. of Dermatology |
2017- today |
Senior physician at the University of Magdeburg, Dept. of Dermatology (Director: Prof. Dr. T. Tüting), Head of the immunodermatology and translational research unit |
2014 |
Habilitation "Dermatologie und Allergologie" entitled "Role of the endogenous cannabinoid system for the regulation of allergic inflammation in the skin", University of Bonn |
2014 - 2016 |
Clinical instructor at the Dept. of Dermatology, University of Bonn |
2008 - 2014 |
Research Associate in the Department of Dermatology funded by TP7 in FOR926. Establishment of a junior research group with intramural funding from BONFOR |
2005 - 2007 |
Scientific training with intramural funding from BONFOR in the Lab. of Exp. Dermatology (Prof. Tüting) and the Institute of Mol. Psychiatry (Prof. Zimmer) |
2007 |
Board certification in Dermatology |
2004 |
Approbation |
2003 - 2007 |
Residency in the Department of Dermatology, University of Bonn (Director: Prof. Dr. Dr. T. Bieber) |
2001 - 2003 |
Basic scientific training in the Department of Internal Medicine at the TU Munich for the MD thesis entitled: Influence of cannabinoids and opioids on the activity of smooth muscle cells in the gastric fundus and ileum of rats. |
1995 - 2002 |
Medical school, University of Regensburg and Technical University of Munich |
Membership in scientific societies |
ADF (German Society of Experimental Dermatology) |
Positions in scientific societies |
2017-2022 Board member German Society of Experimental Dermatology (2018-2021 President) |
Editorial Boards |
Journal der Deutschen Dermatologischen Gesellschaft (JDDG) / Section Editor |
Expertenprofil
Molecular mechanisms in the pathogenesis and therapy of melanoma
Regulation of inflammatory immune responses in the skin
Forschung • Kooperationen
Projekte
Kooperationsliste
- FOR 2372, G-Protein-Signalkaskaden: mit neuen molekularen Sonden und Wirkstoffen zu neuen pharmakologischen Konzepten ( Sprecherin: Prof. Evi Kostenis, Universität Bonn)